Concepedia

Mary Nallin Omstead

MN

Statistics

Publications

3

Citations

106

H-Index

3

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Mary Nallin Omstead is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, natural sciences, and organic chemistry.

Top concepts

Publications per year

1991–1996

3

Publications

3

L-687, 781, a new member of the papulacandin family of .BETA.-1,3-d-glucan synthesis inhibitors. I. Fermentation, isolation, and biological activity.

Frank VanMiddlesworth, Mary Nallin Omstead, Dennis M. Schmatz et al. · The Journal of Antibiotics · 1991 · 52 citations · Full text

Restricticin, a novel glycine-containing antifungal agent.

Robert E. Schwartz, Claude Dufresne, James E. Flor et al. · The Journal of Antibiotics · 1991 · 43 citations · Full text

Novel Zaragozic Acids from <i>Leptodontidium elatius</i>

Claude Dufresne, E. Tracy Turner Jones, Mary Nallin Omstead et al. · Journal of Natural Products · 1996 · 11 citations

, , +14

1–3 of 3